The 2nd annual conference of Intl ovarian cancer consortium & symposium on tumor microenvironment & therapeutic resistance Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present


Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, March 29, 2016

The 2nd annual conference of Intl ovarian cancer consortium & symposium on tumor microenvironment & therapeutic resistance

open access
The second annual conference of International ovarian cancer consortium and the symposium on tumor microenvironment and therapeutic resistance


The second Annual Meeting of the International Ovarian Cancer Consortium (IOCC) was held in conjunction with the Symposium on Tumor Microenvironment and Therapeutic Resistance at the Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, and USA. A brief welcoming event along with the banquet on Aug 16th was followed by the eight thematic scientific sessions from August 16 to 18, 2015. Forty-three lectures, organized in eight sessions, were discussed in front of an audience of more than hundred attendees. Emphasis was put on oncogene signaling in cancer genesis and progression, new approaches in Precision Medicine and therapy of ovarian cancer, the role of tumor microenvironment in carcinogenesis, and preventive/curative potential of natural products. In this meeting-report, we highlight the findings and the perspectives in cancer biology and therapeutic strategies that emerged during the conference.


 1. Ovarian Carcinogenesis: Signaling and Stem Cells

 2. Chemoresistance and Cancer Targeted Therapy

 3. Role of Tumor Microenvironment in Cancer Progression

 4. Bioinformatic and Xenograft Technology for Personalized Treatments

 5. Chemoprevention with Natural Products


The conference promoted the gathering of cancer researchers from more than thirty different institutions from nine different countries, thereby offering the participants with a cooperative network environment for future collaboration. The latest advances in the understanding of the biology of cancer and the possible translational impact on the clinical practice of this knowledge for a better management of cancer patients were successfully discussed among the participants. The conference was adjourned with the resolution that the next annual consortium meeting will be held in Oklahoma City while a satellite meeting will be held in South Korea.


Post a Comment

Your comments?